IE38626L - Everinomycin derivatives - Google Patents

Everinomycin derivatives

Info

Publication number
IE38626L
IE38626L IE732232A IE223273A IE38626L IE 38626 L IE38626 L IE 38626L IE 732232 A IE732232 A IE 732232A IE 223273 A IE223273 A IE 223273A IE 38626 L IE38626 L IE 38626L
Authority
IE
Ireland
Prior art keywords
group
derivative
hydroxylamino
everninomicin
nitroso
Prior art date
Application number
IE732232A
Other versions
IE38626B1 (en
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of IE38626L publication Critical patent/IE38626L/en
Publication of IE38626B1 publication Critical patent/IE38626B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Abstract

1454548 Everninomicin derivatives SCHERICO Ltd 10 Dec 1973 [14 Dec 1972 9 July 1973] 57152/73 Heading C2C Novel antibiotic everninomicin derivatives having the general Formula (I) wherein X is a nitroso group, a hydroxylamino group or a nitrone group derivable from the hydroxylamino group, Y is hydrogen or a hydroxy group, and Z is the group when Y is hydroxy, or hydrogen or the group when Y is hydrogen, and pharmaceutically acceptable salts thereof, are prepared by reducing everninomicin B, C or D at the nitro group (i.e. the group corresponding to X) to give a mixture of the corresponding nitroso derivative and hydroxylamino derivative, isolating the required reduction product, and if required, converting the hydroxylamino derivative into the corresponding nitrone by reaction with an aldehyde, or subjecting the hydroxylamino derivative to appropriate oxidation to convert it to the corresponding nitroso derivative, or subjecting the nitroso derivative to appropriate reduction to convert it to the corresponding hydroxylamino derivative. Reduction of the everninomicin B, C or D at the nitro group is effected with aluminium amalgam in aqueous C 1-4 alkanol. Aldehydes used for preparation of the nitrone may be formaldehyde, acetaldehyde, propanol, heptanal, decanal, dodecanal, cyclopropanecarbaldehyde, cyclopentanecarbaldehyde, cyclohexanecarbaldehyde, 3-cyclohexylcarbaldehyde, benzaldehyde, phydroxybenzaldehyde, tolylcarbaldehydes, 3- phenylpropanal, 1- and 2-naphthalene carbaldehydes, 2 - furfuraldehyde, thienylcarbaldehyde, thiazolylcarbaldehyde, pyrazinylcarbaldehyde, and pyranylcarbaldehyde. The oxidation of the hydroxylamino derivative to the nitroso derivative may be effected with alkali metal hypobromite or atmospheric oxygen in the presence of aqueous alkali. The salts of the inventive compounds include those of alkali and alkaline earth metals, (Na, K, Ca), aluminium, triethylamine, procaine, dibenzylamine, N-benzylbetaphenethylamine, N,N<SP>1</SP> - dibenzylethylenediamine, N,N<SP>1</SP> - bis - dehydroabietyl - ethylenediamine, N-ethylpiperidine and N-methylglucamine. The preparation of everninomicins B, C and D by aerobically cultivating Micromonospora carbonacea var. carbonacea or var. aurantiaca is described. The inventive compounds and their salts have antibacterial activity and are formulated into antibiotically active pharmaceutical compositions with an acceptable diluent or carrier. [GB1454548A]
IE2232/73A 1972-12-14 1973-12-10 Novel everninomocin derivatives and process for their preparation IE38626B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31526372A 1972-12-14 1972-12-14
US37734473A 1973-07-09 1973-07-09

Publications (2)

Publication Number Publication Date
IE38626L true IE38626L (en) 1974-06-14
IE38626B1 IE38626B1 (en) 1978-04-26

Family

ID=26979787

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2232/73A IE38626B1 (en) 1972-12-14 1973-12-10 Novel everninomocin derivatives and process for their preparation

Country Status (14)

Country Link
JP (1) JPS4987674A (en)
BG (1) BG23542A3 (en)
CA (1) CA1013739A (en)
CH (1) CH601337A5 (en)
DD (1) DD111575A5 (en)
DE (1) DE2361582A1 (en)
FR (1) FR2210384B1 (en)
GB (1) GB1454548A (en)
HU (1) HU168868B (en)
IE (1) IE38626B1 (en)
IL (1) IL43789A0 (en)
NL (1) NL7316867A (en)
NO (1) NO140306C (en)
PH (1) PH10211A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767748A (en) * 1985-10-15 1988-07-30 Schering Corporation Substituted oligosaccharide antibodies

Also Published As

Publication number Publication date
AU6347573A (en) 1975-06-12
HU168868B (en) 1976-07-28
DD111575A5 (en) 1975-02-20
PH10211A (en) 1976-09-29
NL7316867A (en) 1974-06-18
NO140306C (en) 1979-08-08
NO140306B (en) 1979-04-30
FR2210384A1 (en) 1974-07-12
DE2361582A1 (en) 1974-06-20
FR2210384B1 (en) 1976-08-13
IE38626B1 (en) 1978-04-26
BG23542A3 (en) 1977-09-15
CH601337A5 (en) 1978-07-14
CA1013739A (en) 1977-07-12
GB1454548A (en) 1976-11-03
JPS4987674A (en) 1974-08-22
IL43789A0 (en) 1974-03-14

Similar Documents

Publication Publication Date Title
GB1368267A (en) Insect control
ES438560A1 (en) Production of unsaturated acids from the corresponding aldehydes
US3197466A (en) Penicillin sulfoxides and process
IE41109L (en) Clavulanic acid
US20100130758A1 (en) Method for producing carbonyl compound
KR20020075281A (en) Catalyst for preparation of unsaturated aldehyde and unsaturated carboxcylic acid
US4898989A (en) Alkane oxidation process
RU95109915A (en) Method for production of carboxylic acids and their esters
GB1458704A (en) Process for preparing acrylic acid and catalyst composition for use therein
GB1385685A (en) Cephalosporin derivatives
IE38626L (en) Everinomycin derivatives
US3897453A (en) Dibenzofuran and dibenzothiophene acetic acid derivatives
JPS6230552A (en) Catalyst for gaseous phase hydrogen moving reaction
GB1440668A (en) Manufacture of ethylbenzene 1-methyl-3-monohalogeno-phenylindans and dihalogen-1-methyl- 3-phenylindans and the manufacture of compounds of these types
GB1162248A (en) Epipodophyllotoxin Derivatives
EP1346766A4 (en) Alkane oxidation catalyst, process for producing the same, and process for producing oxygen-containing unsaturated compound
IE39880L (en) Catalyst: catalytic processes.
DE3365122D1 (en) Catalysts, their preparation and use in vapour phase oxidation of unsaturated aldehydes
GB1377624A (en) Cephalosporin compounds
GB1444272A (en) 17alpha-substituted steroids and their use in the manufacture of spironalactone and a derivative thereof
IE35378L (en) Erythromycylamine compounds
FR2386536A1 (en) PROCESS FOR PREPARING MALEIC ANHYDRIDE BY CATALYTIC OXIDATION OF AN UNSATURE ORGANIC COMPOUND
GB1315053A (en) Process for the manufacture of 1,1,2,2,-tetrahydro-perfluoro-alkan ols
GB1371653A (en) Catalyst
US3153091A (en) Process for the production of cyclohexanone oxime